Oxford Immunotec Global PLC EV/EBIT
What is the EV/EBIT of Oxford Immunotec Global PLC?
The EV/EBIT of Oxford Immunotec Global PLC is N/A
What is the definition of EV/EBIT?
Enterprise value to earnings before interest and taxes (EV/EBIT) is a financial ratio used to measure if a stock is priced appropriately to similar stocks and the market. It is similar to the P/E ratio.
ttm (trailing twelve months)
The EV/EBIT ratio addresses some of the shortcomings of the P/E ratio. Instead of taking market capitalization, the ratio uses enterprise value, as it takes into account the true value of the company. Enterprise value includes both equity and debt. It is calculated as:
Enterprise value = market cap + total debt – cash and cash equivalents
The EV/EBIT ratio is useful in comparing peers within the wider market. A high EV/EBIT ratio indicates that a company’s stock is overvalued. On the opposite, a low EV/EBIT ratio indicates that a company’s stock is undervalued. The lower the ratio, the more financially stable a company should be. However, investors and analyst should use other ratios and information to get a full picture of a company’s financial state and actual value.
EV/EBIT of companies in the Health Care sector on NASDAQ compared to Oxford Immunotec Global PLC
Companies with ev/ebit similar to Oxford Immunotec Global PLC
- Pathfinder Ventures has EV/EBIT of N/A
- Immucell has EV/EBIT of N/A
- Castile Resources has EV/EBIT of N/A
- Blue Blends (India) has EV/EBIT of N/A
- Puxin has EV/EBIT of N/A
- Ansal Properties & Infrastructure has EV/EBIT of N/A
- Oxford Immunotec Global PLC has EV/EBIT of N/A
- Summit Midstream Partners LP has EV/EBIT of N/A
- Goliath Resources has EV/EBIT of N/A
- Affirm has EV/EBIT of N/A
- Spey Resources Corp has EV/EBIT of N/A
- Radaan Mediaworks India has EV/EBIT of N/A
- Impact Acquisitions has EV/EBIT of N/A